Date Filed | Type | Description |
02/27/2023 |
4
| Hamill John P. (SrVP/CFO/Prin Fin & Acct Ofcr) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Granted 1,000 shares
@ $5.25, valued at
$5.3k
|
|
01/30/2023 |
4
| Hamill John P. (SrVP/CFO/Prin. Fin&Acctg. Off) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Granted 269,879 shares
@ $0 Granted 539,758 options to buy
@ $0.496, valued at
$267.7k
|
|
01/30/2023 |
3
| Hamill John P. (SrVP/CFO/Prin. Fin &Acctg. Off) has filed a Form 3 on Aprea Therapeutics, Inc. |
07/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2021 |
4
| Hamill John P. (SVP & CFO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Granted 60,000 options to buy
@ $5.44, valued at
$326.4k
|
|
10/09/2020 |
4
| Hamill John P. (SVP & CFO) has filed a Form 4 on WINDTREE THERAPEUTICS INC /DE/
Txns:
| Bought 1,000 shares
@ $5.27, valued at
$5.3k
|
|
07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/04/2019 |
4
| Hamill John P. (VP Fin,Princ Fin&Acct Officer) has filed a Form 4 on TREVENA INC
Txns:
| Bought 7,500 shares
@ $1.16, valued at
$8.7k
Paid exercise price by delivering 5,516 shares
@ $1.17, valued at
$6.5k
|
|
12/10/2018 |
4
| Hamill John P. (VP Fin,Princ Fin&Acct Officer) has filed a Form 4 on TREVENA INC
Txns:
| Granted 80,000 shares
@ $0 |
|
09/04/2018 |
4
| Hamill John P. (VP Fin,Princ Fin&Acct Officer) has filed a Form 4 on TREVENA INC
Txns:
| Granted 52,500 options to buy
@ $1.8, valued at
$94.5k
|
|
06/13/2018 |
3
| Hamill John P. (Int. Prin. Fin. Off. and PAO) has filed a Form 3 on TREVENA INC |
09/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |